The enhancement makes the 2320EXT device one of the few good manufacturing practices (GMP) compliant sample preparation systems available in the worldwide life sciences market today, the company said.
The machine is mainly used to prepare samples (tissues, cells, proteins) for analysis and has been installed in research and manufacturing laboratories worldwide.
"GMP compliance is not only mandated by the U.S. Food and Drug Administration and equivalent regulatory bodies worldwide, it is also widely accepted by the world's biopharmaceutical companies as the best - if not the only - way to bring a new product to market," noted Dr Alexander Lazarev, the vice president of R&D (research and development) at Pressure BioSciences.
GMP covers all aspects of production, from starting materials to the final released product.
Having GMP-compliant features should allow the Barocycler 2320EXT to be used in multiple departments within the same company, and for multiple applications, said the US-listed firm.
Sample preparation is often complex, time-consuming, and one of the most error-prone steps in research.
It is also a large and growing market, estimated currently at US$6 billion worldwide.
It's been a busy month for Pressure BioSciences.
It has announced the acquisition of all assets of BaroFold Inc, which is expected to enhance revenues and increase its IP (intellectual property) portfolio.
BaroFold, among other assets, has developed PreEMT technology, which improves the quality of manufacturing biopharma products and decreases manufacturing costs (by as much as US$2-10mln per year per commercial biologic drug), the firm said.